HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
18.16
-0.83 (-4.37%)
At close: Apr 26, 2024, 4:00 PM
18.24
+0.08 (0.44%)
After-hours: Apr 26, 2024, 7:55 PM EDT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $3.16 billion as of April 26, 2024. Its market cap has increased by 8.84% in one year.
Market Cap
3.16B
Enterprise Value
2.36B
1-Year Change
8.84%
Ranking
Category
Stock Price
$18.16
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $3.16B, an increase of 98.13%. That is a compound annual growth rate of 8.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 3.31B | 3.15% |
Apr 24, 2024 | 3.21B | 0.88% |
Apr 23, 2024 | 3.18B | 7.73% |
Apr 22, 2024 | 2.95B | 2.67% |
Apr 19, 2024 | 2.88B | 0.85% |
Apr 18, 2024 | 2.85B | -0.54% |
Apr 17, 2024 | 2.87B | -1.38% |
Apr 16, 2024 | 2.91B | -5.55% |
Apr 15, 2024 | 3.08B | -1.23% |
Apr 12, 2024 | 3.12B | -1.16% |
Apr 11, 2024 | 3.15B | 2.61% |
Apr 10, 2024 | 3.07B | -1.73% |
Apr 9, 2024 | 3.13B | 6.34% |
Apr 8, 2024 | 2.94B | 3.11% |
Apr 5, 2024 | 2.85B | -3.02% |
Apr 4, 2024 | 2.94B | -0.36% |
Apr 3, 2024 | 2.95B | 1.26% |
Apr 2, 2024 | 2.91B | -0.30% |
Apr 1, 2024 | 2.92B | -0.18% |
Mar 28, 2024 | 2.93B | -0.30% |
Mar 27, 2024 | 2.94B | 1.20% |
Mar 26, 2024 | 2.90B | -0.95% |
Mar 25, 2024 | 2.93B | 2.56% |
Mar 22, 2024 | 2.86B | -5.09% |
Mar 21, 2024 | 3.01B | -0.40% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
iRhythm Technologies | 3.45B |
ImmunityBio | 3.44B |
Envista Holdings | 3.44B |
Axonics | 3.39B |
Axsome Therapeutics | 3.39B |
Crinetics Pharmaceuticals | 3.30B |
Evolent Health | 3.27B |
SpringWorks Therapeutics | 3.26B |